Links to Articles

* Nasopharyngeal Cancer by National Cancer Institute

* Nasopharyngeal Cancer Types by Cancer Research UK

* Nasopharyngeal Cancer or Sinus Infection by sinusinfectionhelp.com

* A Genetic Epidemiological Study of
Nasopharyngeal Carcinoma
by Bingjian Feng

* Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China by Wei-Hua Jia, et al.

* Video: 認識鼻咽癌

* 鼻咽癌病友手冊---如何戰勝鼻咽癌 by 黃 淑 珍

* 鼻咽癌治療 by 奇美醫院電腦刀中心主網站

* 長期耳鳴 原來罹鼻咽癌 by 管瑞平

* Familial Tendency and Risk of Nasopharyngeal Carcinoma in Taiwan: Effects of Covariates on Risk by Wan-Lun Hsu, et al.

* Cancer Patterns in Nasopharyngeal Carcinoma Multiplex Families in Taiwan by
Kelly J. Yu, et al.

* Symptom Distress, Catastrophic Thinking, and Hope in Nasopharyngeal Carcinoma Patients by Lai YH, et al.

 

Nasopharyngeal Cancer: Multidisciplinary Management by Jiade J. Lu, et al.

 

The Official Patient's Sourcebook on Nasopharyngeal Cancer: A Revised and Updated Directory for the Internet Age

 

 

The Epstein–Barr virus (EBV) is a virus of the herpes family, which includes herpes simplex virus 1 and 2, and is one of the most common viruses in humans. It is best known as the cause of infectious mononucleosis. It is also associated with particular forms of cancer, particularly Hodgkin's lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma, and central nervous system lymphomas associated with HIV. Finally, there is evidence that infection with the virus is associated with a higher risk of certain autoimmune diseases, especially dermatomyositis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, and multiple sclerosis.

Most people become infected with EBV and gain adaptive immunity.

 

 

Excerpts from Wikipedia.org

Nasopharyngeal carcinoma (NPC; 鼻咽癌) is the most common cancer originating in the nasopharynx, the uppermost region of the pharynx or "throat", where the nasal passages and auditory tubes join the remainder of the upper respiratory tract. NPC differs significantly from other cancers of the head and neck in its occurrence, causes, clinical behavior, and treatment. It is vastly more common in certain regions of East Asia and Africa than elsewhere, with viral, dietary and genetic factors implicated in its causation. It is most common in males.

Epidemiology: NPC is uncommon in the United States and most other nations, but is extremely common in southern regions of China, particularly in Guangdong accounting for 18% of all cancers in China. It is sometimes referred to as Cantonese cancer because it occurs in about 25 cases per 100,000 people in this region, 25 times higher than the rest of the world. It is also quite common in Taiwan. This could be due to the South East Asian diet which typically includes consumption of salted vegetables, fish and meat. While NPC is seen primarily in middle-aged persons in Asia, a high proportion of African cases appear in children. The cause of increased risk for NPC in these endemic regions is not entirely clear.

Symptoms and signs: Cervical lymphadenopathy is the initial presentation in many patients, and the diagnosis of NPC is often made by lymph node biopsy. Symptoms related to the primary tumor include trismus, pain, otitis media, nasal regurgitation due to paresis of the soft palate, hearing loss and cranial nerve palsies. Larger growths may produce nasal obstruction or bleeding and a "nasal twang". Metastatic spread may result in bone pain or organ dysfunction. Rarely, a paraneoplastic syndrome of osteoarthropathy may occur with widespread disease.

Causes: EBV (Epstein-Barr virus) NPC is the most common epithelial cancer in adults. The detection of nuclear antigen associated with Epstein-Barr virus (EBNA) and viral DNA in NPC type 2 and 3, has revealed that EBV can infect epithelial cells and is associated with their transformation . The etiology of NPC (particularly the endemic form) seems to follow a multi-step process, in which EBV, ethnic background, and environmental carcinogens all seem to play an important role. Lo et al. showed that EBV DNA was detectable in the plasma samples of 96% of patients with non-keratinizing NPC, compared with only 7% in controls. More importantly, EBV DNA levels appear to correlate with treatment response and they may predict disease recurrence, suggesting that they may be an independent indicator of prognosis. In adults, other likely etiological factors include genetic susceptibility, consumption of food (in particular salted fish) containing carcinogenic volatile nitrosamines, and as in children, EBV .

Prognosis: Prognostic factors Stage at presentation is the most prognostic factor. The 5-year disease-specific survival (DSS) is as follow: • For stage I à 98% • For stage II A-B à 95% • For stage III à 86% • For stage IV A-B à 73%